Metraipolis › archive › dc_7303cd63f09d

Safety profile of vunakizumab in elderly patients with moderate-to-severe plaque psoriasis: a post-hoc analysis — Europe PMC PMID:41601722

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41601722
DOI: 10.3389/fmed.2025.1695266
License (as archived): solo-consultazione
Archived: 2026-11-06T21:30:34.568Z
SHA-256 of the archived text: 0eabedaba935c0bff141829ff42e85ac05c3389fe228471dd46d6439fbe9d978
Stable URL of this page: https://metraipolis.com/documento/dc_7303cd63f09d

How to cite

Safety profile of vunakizumab in elderly patients with moderate-to-severe plaque psoriasis: a post-hoc analysis — Europe PMC PMID:41601722 — Europe PMC (en), https://europepmc.org/article/MED/41601722 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7303cd63f09d (Metraipolis archive dc_7303cd63f09d, sha256 0eabedaba935c0bff141829ff42e85ac05c3389fe228471dd46d6439fbe9d978)

BibTeX

@misc{dc7303cd63f09d,
  title = {Safety profile of vunakizumab in elderly patients with moderate-to-severe plaque psoriasis: a post-hoc analysis — Europe PMC PMID:41601722},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41601722},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7303cd63f09d; sha256 0eabedaba935c0bff141829ff42e85ac05c3389fe228471dd46d6439fbe9d978},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601722. Agents can read the archived copy with the MCP tool read_document.